Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A21408 | 25344588 | J Lipid Res | Lipoprotein subclass metabolism in nonalcoholic steatohepatitis. | 2014 | Details |
| A21409 | 25343462 | PLoS One | Association between serum irisin levels and non-alcoholic fatty liver disease in health screen examinees. | 2014 | Details |
| A21410 | 25341597 | Turk J Pediatr | Leptin-to-adiponectin ratio in obese adolescents with nonalcoholic fatty liver disease. | 2016 | Details |
| A21411 | 25339832 | World J Gastroenterol | Liver resection and metabolic disorders: an undescribed mechanism leading to postoperative mortality. | 2014 | Details |
| A21412 | 25339829 | World J Gastroenterol | FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation. | 2014 | Details |
| A21413 | 25339808 | World J Gastroenterol | Non-alcoholic fatty liver disease: what has changed in the treatment since the beginning? | 2014 | Details |
| A21414 | 25339807 | World J Gastroenterol | Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease. | 2014 | Details |
| A21415 | 25339806 | World J Gastroenterol | Nonalcoholic fatty liver disease and aging: epidemiology to management. | 2014 | Details |
| A21416 | 25339805 | World J Gastroenterol | Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. | 2014 | Details |
| A21417 | 25336983 | J Inflamm Res | β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model. | 2014 | Details |
| A21418 | 25333896 | Mol Med Rep | Polydatin supplementation ameliorates diet-induced development of insulin resistance and hepatic steatosis in rats. | 2014 | Details |
| A21419 | 25333350 | Mol Med Rep | Inhibition of aldose reductase ameliorates diet-induced nonalcoholic steatohepatitis in mice via modulating the phosphorylation of hepatic peroxisome proliferator-activated receptor α. | 2014 | Details |
| A21420 | 25332112 | Proteomics | Proteomic profile of carbonylated proteins in rat liver: discovering possible mechanisms for tetracycline-induced steatosis. | 2014 | Details |
| A21421 | 25331524 | Hepatology | Systems biological analyses reveal the hepatitis C virus (HCV)-specific regulation of hematopoietic development. | 2015 | Details |
| A21422 | 25331487 | Ann Gastroenterol | The hepatoprotective and hypolipidemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population with non-alcoholic fatty liver disease: a prospective pilot study. | 2014 | Details |
| A21423 | 25330278 | Endocr Res | Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects. | 2014 | Details |
| A21424 | 25330059 | Cell Transplant | Preoperative hepatocyte transplantation improves the survival of rats with nonalcoholic steatohepatitis-related cirrhosis after partial hepatectomy. | 2014 | Details |
| A21425 | 25328713 | Int J Hepatol | Fructose induced endotoxemia in pediatric nonalcoholic Fatty liver disease. | 2014 | Details |
| A21426 | 25328157 | Br J Nutr | Astaxanthin lowers plasma TAG concentrations and increases hepatic antioxidant gene expression in diet-induced obesity mice. | 2014 | Details |
| A21427 | 25327387 | Expert Rev Gastroenterol Hepatol | Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease. | 2014 | Details |
| A21428 | 25326588 | Toxicol Pathol | Identification of Environmental Chemicals Associated with the Development of Toxicant-associated Fatty Liver Disease in Rodents. | 2014 | Details |
| A21429 | 25326152 | J Gastroenterol | Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease. | 2014 | Details |
| A21430 | 25325563 | Br J Nutr | Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review. | 2014 | Details |
| A21431 | 25324136 | Horm Res Paediatr | Non-alcoholic fatty liver and metabolic syndrome in children: a vicious circle. | 2014 | Details |
| A21432 | 25320541 | World J Gastroenterol | Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population. | 2014 | Details |
| A21433 | 25320186 | J Nutr | Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women. | 2014 | Details |
| A21434 | 25319795 | Int J Mol Med | Obesity increases histone H3 lysine 9 and 18 acetylation at Tnfa and Ccl2 genes in mouse liver. | 2014 | Details |
| A21435 | 25319715 | Indian J Gastroenterol | Apolipoprotein C3 gene polymorphisms in Southern Indian patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A21436 | 25318838 | J Gastroenterol Hepatol | Association between serum calcium and phosphorus concentrations with non-alcoholic fatty liver disease in Korean population. | 2015 | Details |
| A21437 | 25318054 | Int J Mol Sci | Effects of the olive-derived polyphenol oleuropein on human health. | 2014 | Details |
| A21438 | 25317840 | Food Funct | Lactobacillus plantarum NCU116 improves liver function, oxidative stress and lipid metabolism in rats with high fat diet induced non-alcoholic fatty liver disease. | 2014 | Details |
| A21439 | 25317812 | Eur Rev Med Pharmacol Sci | The impact of small doses of LPS on NASH in high sucrose and high fat diet induced rats. | 2014 | Details |
| A21440 | 25317811 | Eur Rev Med Pharmacol Sci | Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH). | 2014 | Details |
| A21441 | 25316683 | JPEN J Parenter Enteral Nutr | Branched-Chain Amino Acid-Rich Supplements Containing Microelements Have Antioxidant Effects on Nonalcoholic Steatohepatitis in Mice. | 2014 | Details |
| A21442 | 25314137 | PLoS One | Mmu-miR-615-3p regulates lipoapoptosis by inhibiting C/EBP homologous protein. | 2014 | Details |
| A21443 | 25313081 | Proc Natl Acad Sci U S A | Obesity accelerates epigenetic aging of human liver. | 2014 | Details |
| A21444 | 25312970 | J Mol Endocrinol | Aberrant miR199a-5p/caveolin1/PPARα axis in hepatic steatosis. | 2014 | Details |
| A21445 | 25312648 | Mol Cell Biol | Hepatic mitogen-activated protein kinase phosphatase 1 selectively regulates glucose metabolism and energy homeostasis. | 2014 | Details |
| A21446 | 25312517 | Liver Transpl | Mitochondrial dysfunction in steatotic rat livers occurs because a defect in complex i makes the liver susceptible to prolonged cold ischemia. | 2015 | Details |
| A21447 | 25311610 | Nutr Res | Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A21448 | 25311381 | Clin Gastroenterol Hepatol | Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile. | 2014 | Details |
| A21449 | 25310763 | Pediatr Res | Gut microbiome and nonalcoholic fatty liver diseases. | 2014 | Details |
| A21450 | 25310404 | PLoS One | The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease. | 2014 | Details |
| A21451 | 25310357 | Mol Med Rep | Ezetimibe prevents the development of non‑alcoholic fatty liver disease induced by high‑fat diet in C57BL/6J mice. | 2014 | Details |
| A21452 | 25310017 | Food Funct | Total saponins from Rosa laevigata Michx fruit attenuates hepatic steatosis induced by high-fat diet in rats. | 2014 | Details |
| A21453 | 25309705 | Korean J Fam Med | The impact of weight changes on nonalcoholic Fatty liver disease in adult men with normal weight. | 2014 | Details |
| A21454 | 25309079 | World J Gastroenterol | Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease. | 2014 | Details |
| A21455 | 25309067 | World J Gastroenterol | Nonalcoholic fatty liver disease and vascular disease: state-of-the-art. | 2014 | Details |
| A21457 | 25307311 | Mini Rev Med Chem | Long chain omega-3 polyunsaturated fatty acids in pediatric metabolic syndrome. | 2014 | Details |
| A21458 | 25306468 | Transplant Rev (Orlando) | Liver disease in kidney transplant recipients. | 2014 | Details |
| A21459 | 25306266 | J Dairy Sci | Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease. | 2014 | Details |
| A21460 | 25305772 | Arch Iran Med | Systematic review: endocrine abnormalities in patients with liver cirrhosis. | 2014 | Details |
| A21462 | 25303488 | J Clin Endocrinol Metab | High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels. | 2014 | Details |
| A21463 | 25302830 | Radiology | Nonalcoholic fatty liver disease: portal hypertension due to outflow block in patients without cirrhosis. | 2014 | Details |
| A21464 | 25302781 | Hepatology | Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity. | 2015 | Details |
| A21465 | 25302503 | PLoS One | Circulating AIM as an indicator of liver damage and hepatocellular carcinoma in humans. | 2014 | Details |
| A21466 | 25300437 | Kidney Blood Press Res | Nonalcoholic fatty liver disease (NAFLD) and cardiovascular risk in renal transplant recipients. | 2014 | Details |
| A21467 | 25299043 | PLoS One | Complement alternative pathway activation in human nonalcoholic steatohepatitis. | 2014 | Details |
| A21468 | 25298375 | Eur J Endocrinol | External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals. | 2014 | Details |
| A21469 | 25297933 | Sci Rep | Variant adiponutrin confers genetic protection against cholestatic itch. | 2014 | Details |
| A21470 | 25297827 | Hepatol Res | Human placental extract treatment for non-alcoholic steatohepatitis non-responsive to lifestyle intervention: A pilot study. | 2014 | Details |
| A21471 | 25296089 | Arq Gastroenterol | Effect of Helicobacter pylori eradication on hepatic steatosis, NAFLD fibrosis score and HSENSI in patients with nonalcoholic steatohepatitis: a MR imaging-based pilot open-label study. | 2015 | Details |
| A21472 | 25296088 | Arq Gastroenterol | Ginseng, green tea or fibrate: valid options for nonalcoholic steatohepatitis prevention? | 2015 | Details |
| A21473 | 25296075 | Arq Gastroenterol | Age and gender may influence the results of Roux-en-Y gastric bypass? Metabolic syndrome parameters. | 2015 | Details |
| A21474 | 25295415 | Horm Metab Res | Influence of plasma cortisol and other laboratory parameters on nonalcoholic Fatty liver disease. | 2014 | Details |
| A21475 | 25295245 | Biomed Res Int | Autophagy and non-alcoholic fatty liver disease. | 2014 | Details |
| A21476 | 25294377 | J Zhejiang Univ Sci B | Association between non-alcoholic fatty liver disease and arterial stiffness in the non-obese, non-hypertensive, and non-diabetic young and middle-aged Chinese population. | 2014 | Details |
| A21477 | 25294219 | Toxicol Sci | Activation of the Nrf2-ARE pathway in hepatocytes protects against steatosis in nutritionally induced non-alcoholic steatohepatitis in mice. | 2014 | Details |
| A21478 | 25293867 | Eur J Clin Invest | Nonalcoholic fatty liver disease vs. obesity on the risk of erosive oesophagitis. | 2014 | Details |
| A21479 | 25292174 | Obesity (Silver Spring) | Obesity depresses the anti-inflammatory HSP70 pathway, contributing to NAFLD progression. | 2014 | Details |
| A21480 | 25291138 | J Clin Gastroenterol | Coffee and liver health. | 2015 | Details |
| A21481 | 25290313 | PLoS One | Association between the PNPLA3 I148M polymorphism and non-alcoholic fatty liver disease in the Uygur and Han ethnic groups of northwestern China. | 2014 | Details |
| A21482 | 25290169 | Exp Mol Pathol | Mallory-Denk Body (MDB) formation modulates Ufmylation expression epigenetically in alcoholic hepatitis (AH) and non-alcoholic steatohepatitis (NASH). | 2014 | Details |
| A21483 | 25289058 | Exp Ther Med | Heparin modulation on hepatic nitric oxide synthase in experimental steatohepatitis. | 2014 | Details |
| A21484 | 25285192 | Frontline Gastroenterol | Non-alcoholic fatty liver disease: a practical approach to treatment. | 2014 | Details |
| A21485 | 25284781 | Cell Rep | Circulating AIM prevents hepatocellular carcinoma through complement activation. | 2014 | Details |
| A21487 | 25282656 | J Nutr Biochem | Protein carbonylation associated to high-fat, high-sucrose diet and its metabolic effects. | 2014 | Details |
| A21488 | 25281898 | Int Immunopharmacol | 3, 3'-Diindolylmethane alleviates steatosis and the progression of NASH partly through shifting the imbalance of Treg/Th17 cells to Treg dominance. | 2014 | Details |
| A21489 | 25281863 | J Hepatol | Acid sphingomyelinase-ceramide system in steatohepatitis: a novel target regulating multiple pathways. | 2014 | Details |
| A21490 | 25281859 | J Hepatol | Hematopoietic overexpression of Cyp27a1 reduces hepatic inflammation independently of 27-hydroxycholesterol levels in Ldlr(-/-) mice. | 2014 | Details |
| A21491 | 25281858 | J Hepatol | TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice. | 2014 | Details |
| A21492 | 25281760 | J Lipid Res | Deletion of ELOVL6 blocks the synthesis of oleic acid but does not prevent the development of fatty liver or insulin resistance. | 2014 | Details |
| A21493 | 25281430 | Diabetes | WISP1 is a novel adipokine linked to inflammation in obesity. | 2014 | Details |
| A21494 | 25278691 | World J Gastroenterol | Non-alcoholic fatty liver disease: what the clinician needs to know. | 2014 | Details |
| A21495 | 25278690 | World J Gastroenterol | Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors. | 2014 | Details |
| A21496 | 25277521 | Eur J Radiol | Intravoxel incoherent motion diffusion imaging of the liver: optimal b-value subsampling and impact on parameter precision and reproducibility. | 2014 | Details |
| A21497 | 25274101 | Br J Nutr | Non-alcoholic fatty liver disease: need for a balanced nutritional source. | 2014 | Details |
| A21498 | 25272224 | Int J Mol Sci | Circulating RNA molecules as biomarkers in liver disease. | 2014 | Details |
| A21499 | 25272018 | Pharm Biol | Houttuynia cordata alleviates high-fat diet-induced non-alcoholic fatty liver in experimental rats. | 2014 | Details |
| A21500 | 25271296 | J Lipid Res | A high-fat diet suppresses de novo lipogenesis and desaturation but not elongation and triglyceride synthesis in mice. | 2014 | Details |
| A21501 | 25271091 | Hepatology | Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: a retrospective study. | 2015 | Details |
| A21502 | 25270373 | Acta Radiol | High resolution in vivo 31P-MRS of the liver: potential advantages in the assessment of non-alcoholic fatty liver disease. | 2014 | Details |
| A21503 | 25269746 | Mol Med Rep | Upregulated microRNA-199a-5p inhibits nuclear receptor corepressor 1 translation in mice with non‑alcoholic steatohepatitis. | 2014 | Details |
| A21504 | 25268946 | PLoS One | Carotid intima-media thickness is predicted by combined eotaxin levels and severity of hepatic steatosis at ultrasonography in obese patients with Nonalcoholic Fatty Liver Disease. | 2014 | Details |
| A21505 | 25268068 | Am J Clin Oncol | Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients: Applicability of the BCLC Staging System. | 2016 | Details |
| A21506 | 25267960 | J Gastrointestin Liver Dis | A potential treatment of non-alcoholic fatty liver disease with SIRT1 activators. | 2014 | Details |
| A21507 | 25267958 | J Gastrointestin Liver Dis | What non-alcoholic fatty liver disease has got to do with obstructive sleep apnoea syndrome and viceversa? | 2014 | Details |
| A21508 | 25267322 | Aliment Pharmacol Ther | Review article: the management of paediatric nonalcoholic fatty liver disease. | 2014 | Details |
| A21509 | 25267215 | Aliment Pharmacol Ther | Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A21510 | 25267016 | Metabolism | Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients. | 2014 | Details |